SCHEMBL2826425

SCHEMBL2826425

CCOC(=O)CCc1ccc(OCc2ccc(Cn3nc(C(C)(C)C)cc3-c3ccccc3)cc2)cc1F

nearest known ligand 0.45

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 15/20 0.45
FFAR4 Q5NUL3 1/20 0.45
SLC16A3 O15427 2/20 0.40
GRN P28799 1/20 0.40
SORT1 Q99523 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
RECQL P46063 1/20 0.40
SLC16A1 P53985 1/20 0.39
MCTS1 Q9ULC4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2825465 0.91 FFAR1 (0.52) FFAR1FFAR4
SCHEMBL2828400 0.90 FFAR1 (0.43) FFAR1FFAR4GRNSORT1ALDH1A1
SCHEMBL2827586 0.89 FFAR1 (0.41) FFAR1FFAR4GRNSORT1ALDH1A1
SCHEMBL2824859 0.89 ALDH1A1 (0.42) FFAR1FFAR4GRNSORT1ALDH1A1
SCHEMBL2826908 0.88 FFAR1 (0.40) FFAR1FFAR4ALDH1A1
SCHEMBL3632856 0.85 FFAR1 (0.46) FFAR1FFAR4SLC16A3GRNSORT1
SCHEMBL2823950 0.82 FFAR1 (0.40) FFAR1FFAR4
SCHEMBL2823942 0.80 FFAR1 (0.50) FFAR1FFAR4GRNSORT1ALDH1A1
SCHEMBL2822493 0.80 FFAR1 (0.49) FFAR1FFAR4GRNSORT1ALDH1A1
SCHEMBL2830023 0.80 FFAR1 (0.49) FFAR1FFAR4GRNSORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1731505-B1 ALKOXYPHENYLPROPANOIC ACID DERIVATIVES TAKEDA PHARMACEUTICAL (JP) 2015-01-14 EP disclosed
EP-2253315-A1 Alkoxyphenylpropanoic acid derivatives Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed
US-7517910-B2 Alkoxyphenylpropanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-14 US disclosed
US-7517910-B2 Alkoxyphenylpropanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-14 US disclosed
US-7517910-B2 Alkoxyphenylpropanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-14 US disclosed
US-20070213364-A1 Alkoxyphenylpropanoic Acid Derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-09-13 US disclosed
US-20070213364-A1 Alkoxyphenylpropanoic Acid Derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-09-13 US disclosed
US-20070213364-A1 Alkoxyphenylpropanoic Acid Derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-09-13 US disclosed
EP-1731505-A1 ALKOXYPHENYLPROPANOIC ACID DERIVATIVES Takeda Pharmaceutical Company Limited (JP) 2006-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213364-A1 Alkoxyphenylpropanoic Acid Derivatives GPR119, FFAR1, GPR55 FFAR1 2/4885FFAR4 6/4885SLC16A3 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.